Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Currently, there is no standard treatment for influenza with related lower respiratory tract
infection (LRTI) in children younger than one year of age, even though influenza related LRTI
is a potentially fatal illness in these children. This study will test a medicine for
influenza in children younger than one year of age to see if it is safe and effective.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)